Dual projection in a two-dimensional curved expanding universe

It is a well known result that the scalar field is composed of two chiral particles (Floreanini-Jackiw particles) of opposite chiralities. Also, that a Siegel particle spectrum is formed by a nonmover field (a Hull's noton) and a FJ particle. In this work we show that in a scalar field spectrum, in a curved expanding universe scenario, we can find two dynamical chiral fields.Comment: 6 pages, Revtex. Final version to appear in Int. J. Mod. Phys.

Superspace Formulation for the BRST Quantization of the Chiral Schwinger Model

It has recently been shown that the Field Antifield quantization of anomalous irreducible gauge theories with closed algebra can be represented in a BRST superspace where the quantum action at one loop order, including the Wess Zumino term, and the anomalies show up as components of the same superfield. We show here how the Chiral Schwinger model can be represented in this formulation.Comment: 11 pages, Late

Chiral boson on a circle revisited

It is a well known result that the scalar field spectrum is composed of two chiral particles (Floreanini-Jackiw particles) of opposite chiralities. Also, that a Siegel particle spectrum is formed by a nonmover field (a Hull's noton) and a FJ particle. We show here that, in fact, the spectrum of the chiral boson on a circle has a particle not present in its currently well known spectrum.Comment: 11 pages, Latex. Final version to appear in Braz. J. Phy

Atopic Dermatitis Host and Environment Model: Revisiting Therapeutic Options

Atopic Dermatitis affects both children and adults and is a serious health concern in many countries. AD is a complex disease with host and environmental factors underlying its pathology. Its treatment is multidimensional reflecting the diverse nature of its triggers and includes emollients, topical steroids and calcineurin inhibitors among others. Immunological dysfunction can be addressed broadly with systemic immunosupressors and specifically with monoclonal antibodies. Dupilumab, which targets IL-4 and IL-13 was granted approval for treatment of moderate-to-severe AD. Biologics targeting IgE/Th2 pathways may have its role in patients with overlapping AD and asthma. Psychological distress can exacerbate symptoms and is associated with increased severity of AD. Environmental triggers, such as, allergens can be addressed in selected cases with allergic immunotherapy. In this paper, we discuss AD treatment and propose a new step-by-step approach aiming at maintaining disease control and improving quality of life.info:eu-repo/semantics/publishedVersio